We envisage that many other diseases affecting the cerebellum such as the recently described FGF14 GAA repeat expansion in late-onset cerebellar ataxia will benefit from investigating patient-derived hCBOs to advance the promise of precision medicine.50 This evidence concerns the gene FGF14 and cerebellar ataxia.